Paragraph 3
The manufacturer or supplier referred to in paragraph 1(b) is a manufacturer or supplier that would be required to make payments under regulation 3 or under a direction given under regulation 4 for a period of one or more of their complete accounting reference periods were it not for the fact that regulation 3(6) or 4(5) applied.
Table 1
| Column (1)Length of current accounting reference period | Column (2)Likely net sales income |
|---|---|
| Twelve months | F1£6 million |
| Less than twelve months | £6 million as proportionately reduced to the number of months in the manufacturer's or supplier's accounting reference period |
| More than twelve months | £6 million as proportionately increased to the number of months in the manufacturer's or supplier's accounting reference period |
Table 2
| Column (1)Length of previous accounting reference period | Column (2)Net sales income |
|---|---|
| Twelve months | F2£6 million |
| Less than twelve months | £6 million as proportionately reduced to the number of months in the manufacturer's or supplier's accounting reference period |
| More than twelve months | £6 million as proportionately increased to the number of months in the manufacturer's or supplier's accounting reference period |
Annotations
Textual amendments
- F1
Sum in Sch. 2 para. 3 Table 1 substituted (1.1.2025) by The Branded Health Service Medicines (Costs) (Amendment) Regulations 2024 (S.I. 2024/1277), regs. 1(1), 15
- F2
Sum in Sch. 2 para. 3 Table 2 substituted (1.1.2025) by The Branded Health Service Medicines (Costs) (Amendment) Regulations 2024 (S.I. 2024/1277), regs. 1(1), 15